尿液反应预测与心力衰竭中的MELD得分
Volkan Kozluca1, Irem Muge Akbulut1, Turkan Seda Tan1
1Ankara University Department of Cardiology, Ankara, Turkey.
Clinical cardiology
|December 26, 2025
概括
MELD得分衍生品可以帮助预测心力衰竭患者的利尿反应,从而有可能改善治疗策略. 这一发现可能有助于更好地管理心力衰竭表型和结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 心力衰竭 (HF) 给全球死亡率带来了重大挑战.
- 不同的HF表型使治疗复杂化,尿液反应 (DR) 有显著差异.
- 尿路参数正在成为预测DR的工具.
研究的目的:
- 调查末期肝病模型 (MELD) 评分作为未补偿心力衰竭患者尿液反应 (DR) 的额外预测指标的实用性.
- 评估MELD得分衍生和DR之间的关联,特别是与尿液水平有关.
主要方法:
- 分析了81名没有补偿的心力衰竭的患者.
- 尿液二小时内 (UNa) 和血清参数在利尿剂后被记录下来.
- 评估了MELD得分衍生品,以评估它们对DR的预测能力.
主要成果:
- MELD Na评分显示了与DR的独立关联 (OR=0.88;p=0.008).
- MELD Na 评分与尿中的水平有显著的相关性 (r=-0.354;p=0.004).
- 患有低DR (低UNa) 的患者需要更高剂量的furosemide,并且住院时间更长.
结论:
- MELD得分衍生品,特别是MELD Na,与心力衰竭患者的利尿反应有关.
- MELD得分衍生品可以作为一个有价值的额外参数来预测DR.
- 这一发现可能会导致更个性化,更有效的心力衰竭管理策略.
相关概念视频
01:22Heart Failure Drugs: Diuretics
763
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
763
01:30Heart Failure V: Medical Management
196
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
196
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
874
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
874
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
166
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
166
01:30Heart Failure IV: Classification and Diagnostic Evaluation
290
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
290
01:28Mitral Regurgitation IV: Nursing Management
286
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
286